New VALID Act Would Establish Risk-Based System for LDTs Regulation
Senate committee members propose a modified version of legislation allowing the FDA to continue to regulate LDTs on a risk-tiered basis.
Senate committee members propose a modified version of legislation allowing the FDA to continue to regulate LDTs on a risk-tiered basis.
The Biden administration released another statement on Wednesday reminding lawmakers of the consequences of not resolving the issue quickly.
Recently introduced bill would require coverage of genomic cancer testing and follow-up screening for certain at-risk individuals.
While HHS hasn’t yet officially withdrawn SUNSET, recent indications are that it’s only a matter of time.
The relief package agreed to on April 4 appears to have become a collateral victim of a politically incendiary issue regarding immigration.